We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register for real-time alerts, custom portfolio, and market movers
| Share Name | Share Symbol | Market | Type |
|---|---|---|---|
| Neurocrine Biosciences Inc | NASDAQ:NBIX | NASDAQ | Common Stock |
| Price Change | % Change | Share Price | Shares Traded | Last Trade
|
|
|---|---|---|---|---|---|
| -1.77 | -1.28% | 135.99 | 717,575 | 01:00:00 |
| Bid Price | Offer Price | High Price | Low Price | Open Price | |
|---|---|---|---|---|---|
| 125.00 | 144.20 | 138.63 | 135.17 | 137.47 | |
| Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
|---|---|---|---|---|---|
| Biological Pds,ex Diagnstics | 1.89B | 249.7M | 2.5094 | 54.19 | 13.53B |
| Last Trade Time | Trade Type | Trade Size | Trade Price | Currency |
|---|---|---|---|---|
| 22:10:26 | 1 | 135.15 | USD |
| Date | Time | Source | Headline |
|---|---|---|---|
| 05/12/2023 | 21:53 | DJN | Neurocrine Biosciences Gets FDA Breakthrough Therapy Status for Genetic.. |
| 18/8/2023 | 22:33 | DJN | Neurocrine Biosciences' Ingrezza Gets FDA Approval |
Neurocrine Biosciences (NBIX) Share Charts1 Year Neurocrine Biosciences Chart |
|
1 Month Neurocrine Biosciences Chart |
Intraday Neurocrine Biosciences Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
